Hims & Hers Health Inc (HIMS)

$30.49 +2.34 (8.31%)
Market Cap 6.61B
Revenue (ttm) 2.35B
Net Income (ttm) 128.37M
EPS (ttm) N/A
PE Ratio 59.52
Forward PE 49.18
Profit Margin 5.47%
Debt to Equity Ratio 0.00
Volume 30,629,612
Avg Vol 38,894,730
Day's Range N/A - N/A
Shares Out 227.94M
Stochastic %K 70%
Beta 2.32
Analysts Sell
Price Target $25.61

Company Profile

Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health a...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 415 851 0195
Address:
2269 Chestnut Street, Suite 523, San Francisco, United States
Aceinphilly1
Aceinphilly1 Apr. 24 at 5:26 PM
$HIMS this will run to 40-50 before earnings imo
0 · Reply
Amr_Samra
Amr_Samra Apr. 24 at 5:23 PM
$HIMS If $HIMS closes today up around 6%, I would be very satisfied. In my view, that would be a reasonable and healthy move given the stock’s recent behavior and today’s momentum. A strong close matters more than just an intraday spike.
0 · Reply
stockwarrior86
stockwarrior86 Apr. 24 at 5:22 PM
$HIMS another bull flag or is this gonna break down
0 · Reply
Biofocuses
Biofocuses Apr. 24 at 5:19 PM
$HIMS can't believe I have to buy back in fff
0 · Reply
Chingying
Chingying Apr. 24 at 5:18 PM
$HIMS Overweight rating PT$ 35 JPM
0 · Reply
ajmore
ajmore Apr. 24 at 5:16 PM
$LLY $NVO $HIMS $LLY $SPY
0 · Reply
ajmore
ajmore Apr. 24 at 5:15 PM
$LLY its all about Foundayo and pricing pressure! - $NVO acted smartly, earlier launch, agreement with $HIMS , agreement with Trump. They knew that last year's prices were too good to last. - $LLY have headwinds! Foundayo is synthetic, over priced and with the fda asking for a trial with respect to liver injury that leaves it too clouded, cloudier than a latte! Valuations will become realistic, same what happened with Novo's share price last year will happen to Lly's share price. PE has to come down, and in very near future, only way, a 550 USD share price.
0 · Reply
Purespeculation
Purespeculation Apr. 24 at 5:13 PM
$HIMS
0 · Reply
mhoward1711
mhoward1711 Apr. 24 at 5:11 PM
$HIMS can’t believe the amount of crayon eaters Trying to still short this at like $16 not long ago
0 · Reply
IholdLongTermStocks
IholdLongTermStocks Apr. 24 at 5:11 PM
$HIMS welp.. definitely no selling here... the strength this has showed at this level just screams pump after shares are done trading hands.
0 · Reply
Latest News on HIMS
Hims & Hers expands into menopause care as estrogen patch demand rises

Apr 22, 2026, 11:27 AM EDT - 2 days ago

Hims & Hers expands into menopause care as estrogen patch demand rises

What's Going On With Hims & Hers Shares

Apr 17, 2026, 10:45 AM EDT - 7 days ago

What's Going On With Hims & Hers Shares

RFK Jr.'s peptide policy could boost Hims & Hers as its GLP-1 business evolves

Apr 16, 2026, 1:44 PM EDT - 7 days ago

RFK Jr.'s peptide policy could boost Hims & Hers as its GLP-1 business evolves

Hims rises as FDA considers broader peptides access; analysts see long-term win

Apr 16, 2026, 11:34 AM EDT - 8 days ago

Hims rises as FDA considers broader peptides access; analysts see long-term win

Hims & Hers surges 4% as peptide policy shift unlocks growth

Apr 16, 2026, 10:42 AM EDT - 8 days ago

Hims & Hers surges 4% as peptide policy shift unlocks growth

Hims & Hers Health Stock Rallies on Regulatory Pivot. It's Not About GLP-1s This Time.

Apr 16, 2026, 8:46 AM EDT - 8 days ago

Hims & Hers Health Stock Rallies on Regulatory Pivot. It's Not About GLP-1s This Time.

Hims & Hers stock jumps as U.S. moves forward with plan to reassess popular peptides

Apr 15, 2026, 5:39 PM EDT - 8 days ago

Hims & Hers stock jumps as U.S. moves forward with plan to reassess popular peptides

Hims & Hers to Announce First Quarter 2026 Financial Results on May 11, 2026

Apr 13, 2026, 4:05 PM EDT - 10 days ago

Hims & Hers to Announce First Quarter 2026 Financial Results on May 11, 2026

HIMS Investors Have Opportunity to Join Hims & Hers Health, Inc. Fraud Investigation with the Schall Law Firm

Apr 8, 2026, 10:21 AM EDT - 16 days ago

HIMS Investors Have Opportunity to Join Hims & Hers Health, Inc. Fraud Investigation with the Schall Law Firm

Hims & Hers Health Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Hims & Hers Health, Inc. - HIMS

Apr 3, 2026, 5:50 PM EDT - 20 days ago

Hims & Hers Health Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Hims & Hers Health, Inc. - HIMS

Telehealth giant Hims & Hers says its customer support system was hacked

Apr 2, 2026, 5:26 PM EDT - 21 days ago

Telehealth giant Hims & Hers says its customer support system was hacked

Novo Nordisk's FDA-Approved GLP-1s Now Available With Hims & Hers

Mar 26, 2026, 12:00 PM EDT - 4 weeks ago

Novo Nordisk's FDA-Approved GLP-1s Now Available With Hims & Hers

OWL, HIMS, TSLA And More: 5 Stocks Investors Couldn't Stop Buzzing About This Week

Mar 14, 2026, 8:00 AM EDT - 5 weeks ago

OWL, HIMS, TSLA And More: 5 Stocks Investors Couldn't Stop Buzzing About This Week

TSLA OWL

Hims & Hers Names Kathryn Beiser as Chief Communications Officer

Mar 10, 2026, 8:08 PM EDT - 6 weeks ago

Hims & Hers Names Kathryn Beiser as Chief Communications Officer

Introducing Hims & Hers Benefits, Unlocking Health & Wellness Discounts for Subscribers

Mar 10, 2026, 9:00 AM EDT - 6 weeks ago

Introducing Hims & Hers Benefits, Unlocking Health & Wellness Discounts for Subscribers

Stock Of The Day: Will Hims & Hers Go Into Another Short Squeeze?

Mar 9, 2026, 3:23 PM EDT - 6 weeks ago

Stock Of The Day: Will Hims & Hers Go Into Another Short Squeeze?

Hims & Hers stock: why today's gains are unlikely to be sustainable

Mar 9, 2026, 1:27 PM EDT - 6 weeks ago

Hims & Hers stock: why today's gains are unlikely to be sustainable

Hims & Hers stock price is surging today. A surprising deal with Novo Nordisk is the reason why

Mar 9, 2026, 11:27 AM EDT - 6 weeks ago

Hims & Hers stock price is surging today. A surprising deal with Novo Nordisk is the reason why

NVO

HIMS Skyrockets on Reported Deal with NVO to Sell GLP-1s

Mar 9, 2026, 11:00 AM EDT - 6 weeks ago

HIMS Skyrockets on Reported Deal with NVO to Sell GLP-1s

NVO

Novo Nordisk drops Him & Hers lawsuit

Mar 9, 2026, 10:38 AM EDT - 6 weeks ago

Novo Nordisk drops Him & Hers lawsuit

NVO

Hims & Hers Stock Pops on a Deal With Rival Novo Nordisk—What You Need to Know

Mar 9, 2026, 10:32 AM EDT - 6 weeks ago

Hims & Hers Stock Pops on a Deal With Rival Novo Nordisk—What You Need to Know

Hims stock jumps 50% as Novo Nordisk ends lawsuit, strikes deal

Mar 9, 2026, 9:23 AM EDT - 6 weeks ago

Hims stock jumps 50% as Novo Nordisk ends lawsuit, strikes deal

Hims & Hers shares surge 50% after Novo Nordisk ends legal feud over compounded weight loss drugs

Mar 9, 2026, 8:52 AM EDT - 6 weeks ago

Hims & Hers shares surge 50% after Novo Nordisk ends legal feud over compounded weight loss drugs

NVO

What's Happening With HIMS Stock?

Mar 9, 2026, 8:35 AM EDT - 6 weeks ago

What's Happening With HIMS Stock?

Novo Nordisk strikes deal for Hims to sell Wegovy and Ozempic, drops lawsuit

Mar 9, 2026, 8:33 AM EDT - 6 weeks ago

Novo Nordisk strikes deal for Hims to sell Wegovy and Ozempic, drops lawsuit

NVO

Hims & Hers Announces Strategic Shift for US Weight Loss Business

Mar 9, 2026, 8:30 AM EDT - 6 weeks ago

Hims & Hers Announces Strategic Shift for US Weight Loss Business

Hims & Hers, Novo Nordisk Weight-Loss Drug Deal Ends Legal Feud, Stock Soars

Mar 9, 2026, 7:04 AM EDT - 6 weeks ago

Hims & Hers, Novo Nordisk Weight-Loss Drug Deal Ends Legal Feud, Stock Soars

NVO

Hims shares jump after report of Novo Nordisk partnership that may end legal feud

Mar 9, 2026, 6:33 AM EDT - 6 weeks ago

Hims shares jump after report of Novo Nordisk partnership that may end legal feud

NVO

Hims & Hers Stock Soars 54%. It's Struck a Truce With Novo Nordisk, Report Says.

Mar 9, 2026, 6:33 AM EDT - 6 weeks ago

Hims & Hers Stock Soars 54%. It's Struck a Truce With Novo Nordisk, Report Says.

NVO

Hims & Hers Shares Double on Report of Wegovy Tie-Up

Mar 9, 2026, 6:06 AM EDT - 6 weeks ago

Hims & Hers Shares Double on Report of Wegovy Tie-Up

Hims & Hers stock rockets on reported end to Novo Nordisk weight-loss drug dispute

Mar 9, 2026, 5:45 AM EDT - 6 weeks ago

Hims & Hers stock rockets on reported end to Novo Nordisk weight-loss drug dispute

NVO

Novo and Hims resolve dispute, will sell obesity drugs together, Bloomberg News reports

Mar 6, 2026, 8:04 PM EST - 6 weeks ago

Novo and Hims resolve dispute, will sell obesity drugs together, Bloomberg News reports

NVO

YieldMax® HIMS Option Income Strategy ETF (HIYY) Trading Halt

Mar 5, 2026, 3:19 PM EST - 7 weeks ago

YieldMax® HIMS Option Income Strategy ETF (HIYY) Trading Halt

HIYY

Hims' pharmacy partner will reintroduce GLP-1 pill pulled from market, Endpoints News reports

Mar 3, 2026, 10:40 AM EST - 7 weeks ago

Hims' pharmacy partner will reintroduce GLP-1 pill pulled from market, Endpoints News reports

Glancy Prongay Wolke & Rotter LLP Announces Investigation of Hims & Hers Health, Inc. (HIMS) on Behalf of Investors

Mar 2, 2026, 12:00 PM EST - 7 weeks ago

Glancy Prongay Wolke & Rotter LLP Announces Investigation of Hims & Hers Health, Inc. (HIMS) on Behalf of Investors

Hims expansion may not come in time for risky GLP-1 business

Mar 2, 2026, 9:16 AM EST - 7 weeks ago

Hims expansion may not come in time for risky GLP-1 business

HIMS Core Business Faces Challenges in Guidance, GLP-1 Prices & NVO

Mar 1, 2026, 4:00 PM EST - 7 weeks ago

HIMS Core Business Faces Challenges in Guidance, GLP-1 Prices & NVO

Law Offices of Howard G. Smith Announces Investigation of Hims & Hers Health, Inc. (HIMS) on Behalf of Investors

Feb 27, 2026, 12:00 PM EST - 2 months ago

Law Offices of Howard G. Smith Announces Investigation of Hims & Hers Health, Inc. (HIMS) on Behalf of Investors

The Law Offices of Frank R. Cruz Announces Investigation of Hims & Hers Health, Inc. (HIMS) on Behalf of Investors

Feb 25, 2026, 7:18 PM EST - 2 months ago

The Law Offices of Frank R. Cruz Announces Investigation of Hims & Hers Health, Inc. (HIMS) on Behalf of Investors

Hims & Hers Health Analysts Cut Their Forecasts After Q4 Results

Feb 24, 2026, 12:46 PM EST - 2 months ago

Hims & Hers Health Analysts Cut Their Forecasts After Q4 Results

KDP Beats & HIMS Misses Sales, QCOM Gains on Upgrades

Feb 24, 2026, 10:30 AM EST - 2 months ago

KDP Beats & HIMS Misses Sales, QCOM Gains on Upgrades

QCOM KDP

Hims & Hers Stock Stumbles - Cautions About Pressure Due To Super Bowl Ad, Change In Shipping Cadences

Feb 24, 2026, 8:32 AM EST - 2 months ago

Hims & Hers Stock Stumbles - Cautions About Pressure Due To Super Bowl Ad, Change In Shipping Cadences

Hims & Hers' expansion plans — as well as its Super Bowl ad — have investors worried about profits

Feb 23, 2026, 7:44 PM EST - 2 months ago

Hims & Hers' expansion plans — as well as its Super Bowl ad — have investors worried about profits

Hims & Hers Health Fourth-Quarter Profit Falls Despite Higher Revenue

Feb 23, 2026, 4:31 PM EST - 2 months ago

Hims & Hers Health Fourth-Quarter Profit Falls Despite Higher Revenue

Hims & Hers Health Reports Mixed Q4 Earnings, Subscribers Cross 2.5 Million

Feb 23, 2026, 4:26 PM EST - 2 months ago

Hims & Hers Health Reports Mixed Q4 Earnings, Subscribers Cross 2.5 Million

Hims & Hers Stock Falls. Why Earnings Are Underwhelming Investors.

Feb 23, 2026, 4:25 PM EST - 2 months ago

Hims & Hers Stock Falls. Why Earnings Are Underwhelming Investors.

Hims & Hers forecasts 2026 revenue above estimates

Feb 23, 2026, 4:15 PM EST - 2 months ago

Hims & Hers forecasts 2026 revenue above estimates

Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results

Feb 23, 2026, 4:05 PM EST - 2 months ago

Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results

HIMS Headwinds Ahead of Earnings

Feb 23, 2026, 9:02 AM EST - 2 months ago

HIMS Headwinds Ahead of Earnings

Aceinphilly1
Aceinphilly1 Apr. 24 at 5:26 PM
$HIMS this will run to 40-50 before earnings imo
0 · Reply
Amr_Samra
Amr_Samra Apr. 24 at 5:23 PM
$HIMS If $HIMS closes today up around 6%, I would be very satisfied. In my view, that would be a reasonable and healthy move given the stock’s recent behavior and today’s momentum. A strong close matters more than just an intraday spike.
0 · Reply
stockwarrior86
stockwarrior86 Apr. 24 at 5:22 PM
$HIMS another bull flag or is this gonna break down
0 · Reply
Biofocuses
Biofocuses Apr. 24 at 5:19 PM
$HIMS can't believe I have to buy back in fff
0 · Reply
Chingying
Chingying Apr. 24 at 5:18 PM
$HIMS Overweight rating PT$ 35 JPM
0 · Reply
ajmore
ajmore Apr. 24 at 5:16 PM
$LLY $NVO $HIMS $LLY $SPY
0 · Reply
ajmore
ajmore Apr. 24 at 5:15 PM
$LLY its all about Foundayo and pricing pressure! - $NVO acted smartly, earlier launch, agreement with $HIMS , agreement with Trump. They knew that last year's prices were too good to last. - $LLY have headwinds! Foundayo is synthetic, over priced and with the fda asking for a trial with respect to liver injury that leaves it too clouded, cloudier than a latte! Valuations will become realistic, same what happened with Novo's share price last year will happen to Lly's share price. PE has to come down, and in very near future, only way, a 550 USD share price.
0 · Reply
Purespeculation
Purespeculation Apr. 24 at 5:13 PM
$HIMS
0 · Reply
mhoward1711
mhoward1711 Apr. 24 at 5:11 PM
$HIMS can’t believe the amount of crayon eaters Trying to still short this at like $16 not long ago
0 · Reply
IholdLongTermStocks
IholdLongTermStocks Apr. 24 at 5:11 PM
$HIMS welp.. definitely no selling here... the strength this has showed at this level just screams pump after shares are done trading hands.
0 · Reply
IRockIce
IRockIce Apr. 24 at 5:06 PM
$HIMS
0 · Reply
Alvarados10
Alvarados10 Apr. 24 at 5:05 PM
$HIMS if you wanna close anywhere between 35-36 that's alright w/me!
0 · Reply
HighRiskHighReward1
HighRiskHighReward1 Apr. 24 at 5:05 PM
$HIMS
0 · Reply
ZiggyMate
ZiggyMate Apr. 24 at 5:03 PM
$HIMS
0 · Reply
IRockIce
IRockIce Apr. 24 at 4:58 PM
$HIMS 3
0 · Reply
m322m
m322m Apr. 24 at 4:57 PM
$HIMS
0 · Reply
Htwomoo
Htwomoo Apr. 24 at 4:50 PM
@goaty
1 · Reply
goaty
goaty Apr. 24 at 4:50 PM
$HIMS LETS FUCKING GOOOOOO WE DESERVE THIS
0 · Reply
goaty
goaty Apr. 24 at 4:49 PM
$HIMS
0 · Reply
Goingtokirkland
Goingtokirkland Apr. 24 at 4:49 PM
$HIMS 32 today?!
0 · Reply
mrdan321
mrdan321 Apr. 24 at 4:48 PM
$HIMS Wants to run…
0 · Reply
Bigg554
Bigg554 Apr. 24 at 4:48 PM
$HIMS well let’s get her trending. This is going to $35 soon so may as well get on and if volume goes nuts squeeze to start your weekend!
0 · Reply